Hospital-pharma clinic partnerships: a bridge too far?
作者信息
Khatib Rani
机构信息
Consultant Pharmacist in Cardiology and Cardiovascular Research, Leeds Teaching Hospitals NHS Trust, and Visiting Associate Professor, University of Leeds Medicines Management & Pharmacy Services, Leeds Teaching Hospitals NHS Trust, Great George Street, Leeds, LS1 3EX.
出版信息
Br J Cardiol. 2022 Oct 11;29(4):31. doi: 10.5837/bjc.2022.031. eCollection 2022.
Abstract
摘要
相似文献
1
Hospital-pharma clinic partnerships: a bridge too far?医院与制药公司的临床合作：跨度太大？
Br J Cardiol. 2022 Oct 11;29(4):31. doi: 10.5837/bjc.2022.031. eCollection 2022.
2
Managing cultural diversity in healthcare partnerships: the case of LIFT.管理医疗保健伙伴关系中的文化多样性：以 LIFT 为例。
J Health Organ Manag. 2011;25(6):645-57. doi: 10.1108/14777261111178538.
3
Beyond Buprenorphine: Models of Follow-up Care for Opioid Use Disorder in the Emergeny Department.超越丁丙诺啡：急诊科阿片类药物使用障碍的随访护理模式。
West J Emerg Med. 2020 Nov 2;21(6):257-263. doi: 10.5811/westjem.2020.7.46079.
4
In-hospital mortality due to acute myocardial infarction. relevance of type of hospital and care provided. RECALCAR study.急性心肌梗死导致的院内死亡率。医院类型及所提供护理的相关性。RECALCAR研究。
Rev Esp Cardiol (Engl Ed). 2013 Dec;66(12):935-42. doi: 10.1016/j.rec.2013.06.006. Epub 2013 Sep 14.
5
GP recruitment and retention: a qualitative analysis of doctors' comments about training for and working in general practice.全科医生的招聘与留用：对医生关于全科医学培训及工作的评论的定性分析
Occas Pap R Coll Gen Pract. 2002 Feb(83):iii-vi, 1-33.
6
Bridging Recovery Initiative Despite Gaps in Entry (BRIDGE): study protocol for a randomized controlled trial of a bridge clinic compared with usual care for patients with opioid use disorder.尽管存在入组差距，但仍进行康复计划（BRIDGE）：一项比较桥接诊所与常规护理对阿片类药物使用障碍患者的随机对照试验的研究方案。
Trials. 2021 Oct 30;22(1):757. doi: 10.1186/s13063-021-05698-4.
7
Are there alternatives to merger?除了合并之外还有其他选择吗？
Health Manpow Manage. 1996;22(5):5-12. doi: 10.1108/09552069610129654.
8
Re-engineering the post-myocardial infarction medicines optimisation pathway: a retrospective analysis of a joint consultant pharmacist and cardiologist clinic model.重新设计心肌梗死后药物优化路径：对联合顾问药剂师和心脏病专家门诊模式的回顾性分析
Open Heart. 2018 Dec 10;5(2):e000921. doi: 10.1136/openhrt-2018-000921. eCollection 2018.
9
Geographic variation in the treatment of non-ST-segment myocardial infarction in the English National Health Service: a cohort study.英国国民医疗服务体系中非ST段抬高型心肌梗死治疗的地域差异：一项队列研究。
BMJ Open. 2016 Jul 12;6(7):e011600. doi: 10.1136/bmjopen-2016-011600.
10
Developing a post-myocardial infarction medicines optimisation clinic: core competencies for upskilling pharmacists and initial patient feedback.开发心肌梗死后药物优化诊所：提高药师技能的核心能力和初步患者反馈。
BMJ Open Qual. 2023 Apr;12(2). doi: 10.1136/bmjoq-2022-002152.
本文引用的文献
1
Innovative, centralised, multidisciplinary medicines optimisation clinic for PCSK9 inhibitors.创新型、集中化、多学科的 PCSK9 抑制剂药物优化诊所。
Open Heart. 2022 Apr;9(1). doi: 10.1136/openhrt-2021-001931.
2
The my experience of taking medicines (MYMEDS) questionnaire for assessing medicines adherence barriers in post-myocardial infarction patients: development and utility.评估心肌梗死后患者药物依从性障碍的 MYMEDS 服药体验问卷：编制与应用
BMC Cardiovasc Disord. 2020 Feb 3;20(1):46. doi: 10.1186/s12872-020-01362-y.
3
Prevalence and coprevalence of chronic comorbid conditions in patients with type 2 diabetes in Catalonia: a population-based cross-sectional study.加泰罗尼亚地区 2 型糖尿病患者慢性共病的患病率和共病率：一项基于人群的横断面研究。
BMJ Open. 2019 Oct 28;9(10):e031281. doi: 10.1136/bmjopen-2019-031281.
4
Re-engineering the post-myocardial infarction medicines optimisation pathway: a retrospective analysis of a joint consultant pharmacist and cardiologist clinic model.重新设计心肌梗死后药物优化路径：对联合顾问药剂师和心脏病专家门诊模式的回顾性分析
Open Heart. 2018 Dec 10;5(2):e000921. doi: 10.1136/openhrt-2018-000921. eCollection 2018.
5
Heart Failure in Type 2 Diabetes Mellitus.2 型糖尿病中的心力衰竭。
Circ Res. 2019 Jan 4;124(1):121-141. doi: 10.1161/CIRCRESAHA.118.311371.
Zotero 插件